{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:37:29Z","timestamp":1648996649854},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.8534-16","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T22:16:09Z","timestamp":1513808169000},"page":"605-611","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosing Corticobasal Syndrome Based on the Presence of Visual Hallucinations and Imaging with Amyloid Positron Emission Tomography"],"prefix":"10.2169","volume":"57","author":[{"given":"Hiroshi","family":"Nishida","sequence":"first","affiliation":[{"name":"Department of Neurology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Departments of Neurology and Geriatrics, Gifu University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Wakida","sequence":"additional","affiliation":[{"name":"Department of Neurology, Gifu Prefectural General Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Dickson DW, Bergeron C, Chin SS, et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 61: 935-946, 2002.","DOI":"10.1093\/jnen\/61.11.935"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 18: 20-33, 1968.","DOI":"10.1001\/archneur.1968.00470310034003"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 53: 795-800, 1999.","DOI":"10.1212\/WNL.53.4.795"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 54 (Suppl 5): S15-S19, 2003.","DOI":"10.1002\/ana.10570"},{"key":"5","first-page":"877","author":"AE Lang","year":"1994","unstructured":"5. Lang AE, Riley DE, Bergeron C. Corticobasal ganglionic degeneration. In: Neurodegenerative Diseases. Calne DB, Ed. WB Saunders, Philadelphia, 1994: 877-894.","journal-title":"Neurodegenerative Diseases","ISSN":"http:\/\/id.crossref.org\/issn\/1660-2854","issn-type":"print"},{"key":"6","unstructured":"6. Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry 83: 405-410, 2012."},{"key":"7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"7. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80: 496-503, 2013.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer&apos;s disease with Pittsburgh Compound-B. Ann Neurol 55: 306-319, 2004.","DOI":"10.1002\/ana.20009"},{"key":"9","unstructured":"9. Bacskai BJ, Frosch MP, Freeman SH, et al. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64: 431-434, 2007."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ikonomovic MD, Klunk WE, Abrahamson EE, et al. Post-mortem correlates of <i>in vivo<\/i> PiB-PET amyloid imaging in a typical case of Alzheimer&apos;s disease. Brain 131: 1630-1645, 2008.","DOI":"10.1093\/brain\/awn016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Matsuda H, Mizumura S, Nemoto K, et al. Automatic voxel-based morphometry of structural MRI by SPM8 plus difeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer disease. AJNR Am J Neuroradiol 33: 1109-1114, 2012.","DOI":"10.3174\/ajnr.A2935"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Josephs KA, Whitwell JL, Boeve BF, et al. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer&apos;s disease. Mov Disord 25: 1246-1252, 2010.","DOI":"10.1002\/mds.23062"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hassan A, Whitwell JL, Josephs KA. The corticobasal syndrome-Alzheimer&apos;s disease conundrum. Expert Rev Neurother 11: 1569-1578, 2011.","DOI":"10.1586\/ern.11.153"},{"key":"14","unstructured":"14. Bensa\u00efdane MR, M-P F, Damasse G, et al. Clinical utility of amyloid imaging in a complex case of corticobasal syndrome presenting with psychiatric symptoms. J Neurol Disord 26: 1-4, 2014."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Burrell JR, Hornberger M, Villemagne VL, Rowe CC, Hodges JR. Clinical profile of PiB-positive corticobasal syndrome. PLoS One 8: e61025, 2013.","DOI":"10.1371\/journal.pone.0061025"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fleisher AS, Chen K, Liu X, et al. Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging 34: 1-12, 2013.","DOI":"10.1016\/j.neurobiolaging.2012.04.017"},{"key":"17","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"17. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872, 2005.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gomperts SN, Locascio JJ, Marquie M, et al. Brain amyloid and cognition in Lewy body diseases. Mov Disord 27: 965-973, 2012.","DOI":"10.1002\/mds.25048"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shimomura T, Mori E, Yamashita H, et al. Cognitive loss in dementia with Lewy bodies and Alzhetmer disease. Arch Neurol 55: 1547-1552, 1998.","DOI":"10.1001\/archneur.55.12.1547"},{"key":"20","unstructured":"20. Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29: 684-693, 2014."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Geda YE, Boeve BF, Negash S, et al. Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci 19: 77-80, 2007.","DOI":"10.1176\/appi.neuropsych.19.1.77"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Bertram K, Williams DR. Visual hallucinations in the differential diagnosis of parkinsonism. J Neurol Neurosurg Psychiatry 83: 448-452, 2012.","DOI":"10.1136\/jnnp-2011-300980"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Bassiony MM, Lyketsos CG. Delusion and hallucination in Alzheimer&apos;s disease. Review of the brain decade. Psychosomatics 44: 388-401, 2003.","DOI":"10.1176\/appi.psy.44.5.388"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56: 643-649, 2001.","DOI":"10.1212\/WNL.56.5.643"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol 11: 170-178, 2012.","DOI":"10.1016\/S1474-4422(11)70289-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Horvath J, Burkhard PR, Herrmann FR, Bouras C, K\u00f6vari E. Neuropathology of parkinsonism in patients with pure Alzheimer&apos;s disease. J Alzheimers Dis 39: 115-120, 2014.","DOI":"10.3233\/JAD-131289"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Cilia R, Rossi C, Frosini D, et al. Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS One 6: e18301, 2011.","DOI":"10.1371\/journal.pone.0018301"},{"key":"28","unstructured":"28. Yoshita M, Arai H, Arai H, et al. Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study. PLoS One 10: e0120540, 2015."},{"key":"29","unstructured":"29. McKeith I, O&apos;Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with <sup>123<\/sup>I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 6: 305-313, 2007."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Haug A, Boyer P, Kluger B. Diffuse Lewy body disease presenting as corticobasal syndrome and progressive supranuclear palsy syndrome. Mov Disord 28: 1153-1155, 2013.","DOI":"10.1002\/mds.25368"},{"key":"31","unstructured":"31. Shimohata T, Aiba I, Nishizawa M. Critera for the diagonosis of corticobasal degeneration. Brain Nerve 67: 513-523, 2015 (in Japanese)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Day GS, Lim TS, Hassenstab J, et al. Differentiating cognitive impairment due to corticobasal degeneration and Alzheimer disease. Neurology 88: 1273-1281, 2017.","DOI":"10.1212\/WNL.0000000000003770"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8534-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T10:17:51Z","timestamp":1570529871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/4\/57_8534-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8534-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}